Genetic testing for cancer susceptibility — ASCO updates policy statement
from Medscape Medical News
The American Society of Clinical Oncology (ASCO) has issued an updated policy statement on genetic and genomic testing for cancer susceptibility. The new document, an update of a statement issued in 2003, was published online in the
Journal of Clinical Oncology
. The update was prompted by an increase in the number of such tests, and it raises two main concerns — the fact that some tests are of unproven clinical benefit, and the fact that some are now being marketed directly to consumers.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063